Vaccine Adjuvants MARKET FORECASTS TO 2028 | DRIVERS AND OPPORTUNITIES | KEY PLAYER ANALYSIS Adjuvatis, Agenus

According to Stratistics MRC, the Global Vaccine Adjuvants Market is accounted for $791.00 million in 2021 and is expected to reach $2,040.87 million by 2028 growing at a CAGR of 14.5% during the forecast period.

Request for a Free Sample Copy of Report at www.strategymrc.com/report/vaccine-adjuvants-market

Adjuvants are fundamentally compounds that improve the body’s immunogenic reaction against antigens. As a result, these are majorly added to vaccines to increase their capability to influence long-term protection and safety against any kind of viruses. Currently, MF59 and aluminum salts are the only adjuvants which are viable for human usage. There have been a lot of developments done on the antigen discovery over the past decade which has enhanced the vaccine development process.

Some of the key players profiled in the Vaccine Adjuvants Market include Adjuvance Technologies, Inc, Adjuvatis, Agenus, Inc, Aphios Corp, Avanti Polar Lipids, CSL Limited, CureVac AG, GSK, Invivogen, Kineta, Inc, MVP Laboratories, Inc, Novartis/CSL, Novavax, Inc, OZ Biosciences, Sergeant Adjuvants, Sigma Aldrich (Merck KGaA), Vaxine Pty Ltd, Vaxliant, Viscogel AB, Sanofi, SK bioscience.

Types Covered: 
• Virus-like Particles   
• Tensoactive Adjuvants         
• Organic Adjuvants    
• Mineral Salt based Adjuvants      
• Liposomes                
• Emulsions             
• Carbohydrates Adjuvants           
• Bacteria-derived Adjuvants      

Products Covered:
• Adjuvant Emulsions    
• Combination Adjuvants    
• Particulate Adjuvants    
• Pathogen Components    
• Saponin     

Disease Types Covered:
• Cancer   
• Infectious Diseases  

Mechanism of Actions Covered:
• Vehicle Adjuvants    
• Carriers        
• Active Immunostimulants

Route of Administrations Covered:
• Subcutaneous Route    
• Oral Route    
• Intranasal Route    
• Intramuscular Route    
• Intradermal Route 

Applications Covered:
• Veterinary Vaccine Adjuvants   
• Human Vaccine Adjuvants

End Users Covered:
• Research Institutes   
• Pharmaceutical Companies   
• Contract Manufacturing Organization   
• Commercial    
• Pediatric   
• Adults       

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

If Any Query? Ask Our Industry Expert at www.strategymrc.com/report/vaccine-adjuvants-market

Explore the list of attractive markets during this time of Pandemic @ www.strategymrc.com/covid-19-impact-reports

About Us:

StrategyMRC research reports and publications are routed to help clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. We track 30+ industries and cover 800 market segments.

Contact Us:

Stratistics Market Research Consulting

Phone: +1-301-202-5929

Email: info@strategymrc.com

Website: www.strategymrc.com/

Twitter:twitter.com/StratisticsMRC

LinkedIn: www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile

Request Sample